Amadix

🔎 En España, el cáncer colorrectal es el tumor más frecuente y el segundo en mortalidad, pero la participación en los programas de cribado apenas alcanza el 42%. El nuevo Libro Blanco sobre Cribado de Cáncer Colorrectal propone estrategias para mejorar esta cifra y reducir las disparidades regionales, con el objetivo de alcanzar una cobertura del 100% para 2030. ¿Quieres conocer más? Lee la noticia completa de iSanidad. 👉 https://lnkd.in/dwDVRGPf EarlyCancerDetection

#EarlyDetection of polyps and other precancerous lesions is a crucial step in preventing cancer. 🧪🩸 By identifying and removing these growths before they develop into cancer, we can significantly reduce cancer risk and improve long-term outcomes. Advancements in #screening and AI-driven tools are making early detection faster and more accessible. #EarlyCancerDetection

A Global Battle Against Cancer: 12 Groundbreaking Advances 🌍 Cancer remains one challenges we face, claiming around 10 million lives annually. Yet, remarkable innovations in treatment and diagnosis are emerging, sparking new hope. From AI-powered risk profiling to personalized cancer vaccines and breakthrough therapies, technology is reshaping our approach to cancer #EarlyDetection. 🔬We wanted to share some highlights of this World Economic Forum research: 🧪Personalized Vaccines: Trials are underway to tailor vaccines to patients, priming the immune system to target cancer cells effectively. 💡Precision Oncology: A targeted approach to treatment, designed to cause less harm to healthy cells. 💻AI in Cancer Detection: Machine learning models are being deployed to catch cancer earlier paving the way for faster, life-saving diagnoses. 🧬 Check out the full article to learn all about these advancements and the future of cancer care. https://lnkd.in/emcMAEr4 #CancerAwareness #PrecisionMedicine #AIinHealthcare #WorldEconomicForum

💻💡🔬#AI is transforming #CancerDetection by rapidly analyzing large datasets, significantly reducing the time needed for diagnosis. This enables #earlystage detection, allowing for timely and more effective treatments tailored to each patient. With personalized medicine, each patient’s unique genetic profile and cancer biomarkers are used to create customized treatment plans. This approach enhances the precision of therapies, reducing side effects and improving overall outcomes by targeting cancer more effectively. #EarlyCancerDetection

We are very pleased that Amadix has been selected for the EIC Scaling Club. It’s great to be part of this esteemed group of 72 innovative and disruptive companies at the European level. I had the privilege of sharing this journey with Noemí Hernandez, and get connected with other remarkable projects and inspiring innovators at the Scale 100 Forum in Athens. This experience has provided valuable insights in a dynamic environment, surrounded by companies, mentors, investors, and organizers. We want to emphasize the collaborative and enriching spirit displayed by all attendees and participating companies, who actively shared their ideas and offer their support to help all projects to scale!

🧪🔬💻Exciting advances in colorectal cancer research! This Nature Magazine study explores how integrating machine learning with #bioinformatics can uncover novel diagnostic gene biomarkers. These breakthroughs hold promise for earlier, more accurate detection, ultimately improving patient outcomes. A powerful step forward in the fight against cancer. #EarlyCancerDetection

🔈 Last week I had the pleasure to attend as a member of Amadix to the third edition of Team PRRC annual summit in Malaga.💡As important take home messages, we can highlight: 🔹The PRRC should not only ensure compliance with the MDR/IVDR, but also with all legislation applicable to medical devices, such as the new IA Act. 🔹Work must be done on the implementation of the IA Act in combination with the IVDR/MDR. 🔹In audits, Notified Bodies (NBs) or Competent Authorities expect that the intervention and action of the PRRC in critical regulatory activities will be reflected in the Quality System documentation. 🔹SMEs are facing difficulties in the transition to IVDR in relation to the associated costs and lack of experience with NBs, especially for IVD SMEs. 🔹Manufacturers need more specification from NBs on what they expect to receive to demonstrate compliance with requirements. This can be achieved through structured dialogues with NBs. 🔹Concern is expressed about the innovation blockade in Europe and the lack of a dedicated pathway for innovative products, such as the Breakthrough Device Program at the FDA. 🔹In Switzerland, they are working towards recognition of FDA approval to ensure, among other things, that the Swedish population has access to innovative medical devices. 🔹UK will update its medical device regulation more closely resembling the IVDR/MDR. I would like to thank AseBio - Asociación Española de Bioempresas for giving me the opportunity to attend, and TEAM-PRRC for organising the event which has allowed us to learn more about the key role that PRRC plays within a company, as well as creating an ideal environment for the exchange of experiences and knowledge between the actors in this sector, being very valuable. #TeamPRRC #IVDR #Compliance

Biomarkers play a critical role in transforming early cancer detection. By identifying specific genes, proteins, or hormones, these indicators provide valuable insights into the presence and progression of cancer. They can help detect cancer early, monitor how well a treatment is working, and even detect if cancer has returned. At Amadix, we are committed to advancing the science of biomarkers through innovative research in liquid biopsy. #EarlyCancerDetection.

🩷 🎗️ Today is #WorldBreastCancerDay, and it’s a powerful reminder of how important #screening is in saving lives. Organizations like @Europa Donna are dedicated to spreading awareness about breast cancer and the life-saving impact of early detection. 💡Since 1989, breast cancer mortality has decreased by 42% thanks to better screening programs and early diagnosis. At Amadix, we are committed to develop early detection technologies, making it possible to catch diseases when they are most treatable. #BreastCancerAwareness #EarlyCancerDetection #Amadix

🩸💡Early detection of colorectal cancer can make all the difference in successful treatment and outcomes. Often, CCR doesn’t show obvious symptoms in the early stages, which is why regular #screenings are so crucial. However, if you notice changes in bowel habits, unexplained weight loss, blood in your stool, or persistent abdominal discomfort, these could be signs that should not be ignored. Taking action early can help prevent CCR from advancing. Stay informed, talk to your doctor, and prioritize regular screeningsearly detection can save lives. Your health is in your hands! #EarlyCancerDetection #Amadix